Cases 11 - 20 of 29
Javelin Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2016cv00224
Plaintiff:
Javelin Pharmaceuticals, Inc. , Hospira, Inc. and Janssen Pharmaceutica N.V.
Defendant:
Mylan Laboratories Limited, Mylan Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. SUN PHARMACEUTICAL INDUSTRIES LTD et al
as 3:2016cv01727
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
SUN PHARMACEUTICAL INDUSTRIES LTD, SUN PHARMA GLOBAL FZE, MYLAN INC. and others
Cause Of Action: 35 U.S.C. § 271
Warner Chilcott (US), LLC et al v. Mylan Pharmaceuticals, Inc. et al
as 2:2015cv01740
Plaintiff:
Warner Chilcott (US), LLC , Warner Chilcott Company, LLC and Qualicaps Co., Ltd.
Defendant:
Mylan Pharmaceuticals, Inc. , Mylan Laboratories Limited and Mylan, Inc.
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00185
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GMBH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Fresenius Kabi USA, LLC et al v. Mylan Laboratories Limited et al
as 1:2015cv00942
Plaintiff:
Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH
Defendant:
Mylan Laboratories Limited, Mylan Inc., Agila Specialties Inc. and others
Cause Of Action: 35 U.S.C. § 271
Astrazeneca Pharmaceuticals LP et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00183
Plaintiff:
Astrazeneca Pharmaceuticals LP , Astrazeneca UK Limited and AstraZeneca AB
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
ASTRAZENECA PHARMACEUTICALS LP et al v. MYLAN PHARMACEUTICALS INC. et al
as 1:2015cv07009
Plaintiff:
ASTRAZENECA PHARMACEUTICALS LP , ASTRAZENECA UK LIMITED and ASTRAZENECA AB
Defendant:
MYLAN PHARMACEUTICALS INC. , MYLAN INC. and MYLAN LABORATORIES LIMITED
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals, Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2015cv00145
Plaintiff:
Boehringer Ingelheim Pharmaceuticals, Inc. , Boehringer Ingelheim International GmbH , Boehringer Ingelheim Corporation and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 3:2015cv05982
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM CORPORATION and others
Defendant:
HEC PHARM GROUP , HEC PHARM CO., LTD. , HEC PHARM USA and others
Counter_claimant:
SUN PHARMACEUTICAL INDUSTRIES, INC. , SUN PHARMACEUTICAL INDUSTRIES LTD. , SUN PHARMA GLOBAL FZE and others
Counter_defendant:
BOEHRINGER INGELHEIM CORPORATION , BOEHRINGER INGELHEIM INTERNATIONAL GMBH , BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ELI LILLY AND COMPANY v. MYLAN LABORATORIES LIMITED et al
as 1:2015cv01083
Plaintiff:
ELI LILLY AND COMPANY
Defendant:
MYLAN INC., MYLAN LABORATORIES LIMITED and MYLAN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
